Browsing by Author rp01659

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 390 to 409 of 557 < previous   next >
TitleAuthor(s)Issue Date
 
Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation
Journal:Hepatoma Research
Fung, JYYWong, DKHTanaka, YLo, CLRWong, CLTChok, KSHChan, ACYCheung, TTDai, WCNg, KCKNg, KTPMan, KNg, IOLSeto, WKWLai, CLYuen, RMFLo, CM
2018
 
Quantitative hepatitis B surface antigen levels in patients with chronic hepatitis B after 2 years of entecavir treatment
Journal:American Journal of Gastroenterology
Fung, JLai, CLYoung, JWong, DKHYuen, JSeto, WKYuen, MF
2011
 
Randomized trial of lamivudine versus entecavir in entecavir-treated patients with undetectable hepatitis B virus DNA: Outcome at 2 Years
Journal:Hepatology
Fung, JLai, CLYuen, JCheng, CWu, RKaHo Wong, DSeto, WKHung, IFNYuen, MF
2011
 
Rates of metachronous adenoma after curative resection for left-sided or right-sided colon cancer
Journal:Intestinal Research
Lam, YFSeto, WKWTong, SMCheung, KSMLo, OSHHung, FNILaw, WLLeung, WK
2018
 
Real-Life Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir, and Dasabuvir in Chronic Hepatitis C Patients in Hong Kong
Journal:Journal of Gastroenterology and Hepatology
Chan, HLYTsang, OTYHui, YTFung, JYYLui, GCYLai, CLWong, GLHChan, KHBut, YKDLai, MSLao, WCChan, CKMLam, YSSeto, WKWLi, CYuen, RMFWong, VWS
2017
 
Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B
Journal:Gut
Poh, ZShen, LYang, HISeto, WKWWong, VWLin, CYGoh, BBChang, PEChan, HLYYuen, RMFChen, CJTan, CK
2016
 
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable cccDNA
Proceeding/Conference:Hepatology
Lai, CLWong, DKHYuen, JCHWu, CHCheng, CTKNgai, WSKopaniszen, MSeto, WKWFung, JYYYuen, RMF
2017
 
Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed circular DNA
Journal:JHEP Reports
Lai, C-LWong, DK-HWong, GT-YSeto, W-KFung, JYuen, M-F
2020
 
Recent advances in the diagnosis and therapy of liver fibrosis and cirrhosis
Proceeding/Conference:Dongguan Gastroenterology Conference
Seto, WKW
2018
 
Reduced changes in bone mineral density in Chronic HBV (CHB) Patients receiving Tenofovir Alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF)
Proceeding/Conference:The Liver Meeting® 2016
Seto, WKWAsahina, YPeng, CYStanciu, CAbdurakhmanov, DFlaherty, JKim, KGaggar, ASubramanian, MTabak, FNguyen, TTChan, HLY
2016
 
Reduced changes in bone mineral density in chronic hepatitis B patients receiving TAF compared with TDF
Proceeding/Conference:Conference of the Asian Pacific Association for the Study of the Liver, APASL 2017
Seto, WKWAsahina, YPeng, CYStanciu, CAbdurakhmanov, DFlaherty, JKim, LGaggar, ASubramanian, MTabak, FNguyen, TTChan, HLY
2017
 
Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection
Journal:Hepatology International
Mak, LYHui, RWHFung, JLiu, FWong, DKHLi, BCheung, KSYuen, MFSeto, WK
2021
 
Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B
Journal:Journal of Hepatology
Lai, CLWong, DKHIp, PCPKopaniszen, MSeto, WKWFung, JYYHuang, FYLee, BCullaro, GChong, CKWu, CHCheng, CTKYuen, JCHNgai, WSYuen, RMF
2017
 
Reduction of hepatitis B core related antigen by long term nucleoside nucleotide analogue therapy and its correlation with intrahepatic HBV DNA reduction
Proceeding/Conference:Hepatology International
Wong, DKopaniszen, MSeto, WKFung, JHung, IYoung, JLPYuen, JCHNgai, VWSYuen, MFLai, CL
2015
 
Reduction of Hepatitis B Surface Antigen and Covalently Closed Circular DNA by Nucleos(t)ide Analogues of Different Potency
Journal:Clinical Gastroenterology and Hepatology
Wong, DKHSeto, WKWFung, JYYIp, PPCHuang, FYLai, CLYuen, RMF
2013
 
Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleoside/nucleotide analogues of different potency
Proceeding/Conference:State Key Laboratory for Liver Research Symposium, SKLLR 2012
Wong, DKHSeto, WKWFung, JYYHuang, FYLai, CLYuen, RMF
2012
 
Reduction of hepatitis B surface antigen levels and hepatitis B surface antigen seroclearance in chronic hepatitis B patients receiving 10 years of nucleoside analogue therapy
Journal:Hepatology
Seto, WKWWong, DKHFung, JYYHuang, FYLai, CLYuen, RMF
2013
 
Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B
Journal:Hepatology International
Fung, JLai, CLBut, DHsu, ASeto, WKCheng, CWong, DKHYuen, MF
2010
 
Regression of liver fibrosis after HBsAg loss: a prospective matched case-control evaluation using transient elastography and serum Enhanced Liver Fibrosis (ELF) test
Proceeding/Conference:Hepatology International
Mak, LYWong, DKHHui, WHRCheung, KSMLiu, FFung, JYYSeto, WKWYuen, RMF
2021
 
Regression of liver fibrosis after HBsAg loss: a prospective matched case-control evaluation using transient elastography and serum Enhanced Liver Fibrosis (ELF) test
Proceeding/Conference:Hepatology International
Mak, LYWong, DKHHui, WHRCheung, KSMLiu, FFung, JYYSeto, WKWYuen, RMF
2021
Showing results 390 to 409 of 557 < previous   next >